by Eric Christianson | May 25, 2022 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the...
by Eric Christianson | Feb 20, 2022 | Clinical Guideline Updates For Pharmacists
I recently blogged about my thoughts on the new diabetes guidelines. After that post, my friend Derek Borkowski who is the founder of Pyrls.com messaged me to offer followers of the Meded101 blog a free download. He’s put together a phenomenal resource with his...
by Eric Christianson | Jan 12, 2022 | Clinical Guideline Updates For Pharmacists
The American Diabetes Association released their 2022 Diabetes Guidelines update. While I wouldn’t call the changes earth-shattering, there are some items in relation to pharmacotherapy that I feel are really important to note. The patient population that I work...
by Eric Christianson | Oct 20, 2021 | Educational Case Studies For Pharmacists
CA is a 58-year-old female with CKD. Her CrCL today is 45 mL/min and stable sCr of 1.3 mg/dL. She complains of muscle aches that started a couple of weeks ago and that her doctor said she can’t use NSAIDs, even though the Tylenol doesn’t completely help the pain. She...
by Eric Christianson | Sep 29, 2021 | Pharmacist Legislative Advocacy
I’ve worked with so many great pharmacists and we are truly winning the hearts and minds of our fellow colleagues. I can’t thank you all enough for how much work you have all put in to grow and develop the profession into what I believe it should be....
